- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01732497
A Prospective Study of Axillary Hair Loss in Patients Treated With the miraDry System
March 30, 2016 updated by: Miramar Labs
The purpose of this study is to evaluate hair reduction in the underarms in patients treated with the miraDry System.
Study Overview
Detailed Description
This study is designed to quantify the amount of hair reduction in patients treated with the miraDry System in the axilla.
Hair counts will be assessed before and after treatments including at follow up visits.
Study Type
Interventional
Enrollment (Actual)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Edina, Minnesota, United States, 55424
- Zel Skin and Laser Specialists
-
-
New York
-
New York, New York, United States, 10016
- Laser & Skin Surgery Center of NY
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, United States, 18017
- Lehigh Valley Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age
- Visible underarm hair (prefer light colored hair; blonde, red, gray)
Exclusion Criteria:
- Secondary Axillary Hyperhidrosis
- Prior surgery and/or Botox Injections in axillae
- Pacemaker or requires supplemental oxygen
- Pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single Group miraDry Treatment
This is a single group study where each enrolled subject will receive active miraDry treatment in each axilla.
|
Application of electromagnetic energy to heat the lower dermis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patients with successful hair reduction
Time Frame: 3 months
|
Percentage of patients that show a >=30% reduction in underarm hair at the 3 month visit compared to baseline.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patients with successful hair reduction
Time Frame: 12 months
|
Percentage of patients that achieve a >=30% reduction in underarm hair at the 12 month visit compared to baseline
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction with hair reduction
Time Frame: All follow-up visits through 12 months
|
Patients will provide their evaluation of satisfaction with the hair reduction seen
|
All follow-up visits through 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kathy Quiroz, BS, RN, Miramar Labs, Inc
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
November 19, 2012
First Submitted That Met QC Criteria
November 19, 2012
First Posted (Estimate)
November 22, 2012
Study Record Updates
Last Update Posted (Estimate)
April 1, 2016
Last Update Submitted That Met QC Criteria
March 30, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP-0009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Underarm Hair
-
Kind Lab PBC.CitruslabsCompleted
-
NovoBliss Research Pvt LtdOrgenetics, Inc.RecruitingDry Skin | Dry Hair | Hair Falling | Thin Hair | Brittle HairIndia
-
Syneron MedicalUnknownExcess Hair GrowthUnited States
-
DeNova ResearchTerminatedHair Loss | Hair ThinningUnited States
-
Healeon Medical IncTerry, Glenn C., M.D.; Ministry of Health, Honduras; Robert W. Alexander, MDEnrolling by invitation
-
NovoBliss Research Pvt LtdZYWIE VENTURES PRIVATE LIMITEDCompletedHair Thinning | Hair Brittle | Dry HairIndia
-
Arbor Life LabsCompletedAndrogenetic Alopecia | Androgenic Alopecia | Hair Loss/Baldness | Hair Thinning | Telogen Effluvium | Thinning HairUnited States
-
BrandiZoneCitruslabsCompletedHair Loss | Hair HealthUnited States
-
Universidad Autonoma de Nuevo LeonHospital Universitario Dr. Jose E. GonzalezCompleted
-
L'OrealVerily Life SciencesRecruiting
Clinical Trials on miraDry Treatment
-
Miramar LabsCompletedAxillary HyperhidrosisCanada
-
Region ÖstergötlandCompletedAxillary HyperhidrosisSweden
-
Johns Hopkins UniversityActive, not recruitingAxillary HyperhidrosisUnited States
-
miraDry, Inc.Withdrawn
-
Cynosure, Inc.CompletedHyperhidrosisUnited States
-
PfizerCompleted
-
PfizerCompleted
-
Chiesi Farmaceutici S.p.A.Completed
-
PfizerCompleted
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States